Health dialogues for patients with mental illness in primary care
This study is testing if having health conversations about lifestyle changes can help people with mental illnesses improve their health and reduce their risk of heart problems over time.
Quick facts
| Phase | Not applicable |
|---|---|
| Study type | Interventional |
| Enrollment | 400 (estimated) |
| Ages | 18 Years and up |
| Sex | All |
| Sponsor | Region Skane Academic / other |
| Locations | 1 site (Helsingborg, Region Skane) |
| Trial ID | NCT05181254 on ClinicalTrials.gov |
What this trial studies
This project follows primary health care patients with mental illnesses such as anxiety, depression, fatigue, and sleep disorders. It involves health conversations and systematic work on lifestyle habits, alongside the assessment of copeptin as a biochemical risk marker. Participants will undergo follow-ups at 12 and 24 months, including health interviews and blood sampling, with long-term follow-up using national registries for up to 20 years regarding cardiovascular complications and mortality. The study aims to evaluate the impact of health dialogues on lifestyle changes and cardiovascular risk factors in this patient population.
Who should consider this trial
Good fit: Ideal candidates are adults over 18 years old seeking primary care for mental health issues like depression, anxiety, or sleep disorders.
Not a fit: Patients with dementia or those who cannot communicate in Swedish may not benefit from this study.
Why it matters
Potential benefit: If successful, this study could lead to improved lifestyle habits and reduced cardiovascular risks for patients with mental illness.
How similar studies have performed: While the specific approach of health dialogues in this context is novel, similar studies have shown promise in improving health outcomes for patients with mental illness.
Eligibility criteria
Show full inclusion / exclusion criteria
Inclusion Criteria: * patients \> 18 years old seeking primary care for mental illness (depression, anxiety, sleep disorders or stress related problems Exclusion Criteria: * Dementia, not speaking, writing or understanding spoken the Swedish language.
Where this trial is running
Helsingborg, Region Skane
- Peter Nymberg — Helsingborg, Region Skane, Sweden (Recruiting)
Study contacts
- Study coordinator: Veronica Milos Nymberg, PhD
- Email: veronica.milos_nymberg@med.lu.se
- Phone: +46 (0)733565679
How to participate
- Review the eligibility criteria above with your treating physician.
- Visit the official trial page on ClinicalTrials.gov for the most current contact information and recruitment status.
- Contact the listed study coordinator or principal investigator to request pre-screening. Pre-screening is free and never obligates you to enroll.